Beauvericin exhibits antitumor activity in pancreatic cancer cells: Integrative analysis suggests potential modulation of the KEAP1-NRF2-HMOX1 axis and survival signaling pathways
To investigate the anticancer effects of Beauvericin (BEA) and elucidate its potential mechanisms in pancreatic cancer cells, a malignancy characterized by marked heterogeneity and frequent chemoresistance. The effects of BEA on the proliferation, migration and apoptosis of Mia PaCa-2 cells were evaluated via CCK-8,...